Rekvina Laboratories Limited, a specialized pharmaceutical company focused on the manufacturing and marketing of therapeutic formulations, has announced the induction of Jay Chintan Patel into its Board of Directors. Appointed as an Additional Non-Executive Independent Director, Patel brings a fresh perspective to the company’s corporate governance framework. His appointment, effective in late January 2026, aligns with the company’s efforts to strengthen independent oversight as it navigates the competitive pharmaceutical landscape and evolving compliance requirements under the SEBI (LODR) Regulations.
Trending
- Congress Leaders to Face Criminal Charges in Rajat Sharma Case
- A New Era of Magic, Josh D’Amaro Appointed Disney CEO
- Anupriya Acharya Makes History as India’s First Jury President for Creative Data Lions
- Pankaj Nihalani Joins Enormous as Head of Creative (Mumbai)
- Sundaram Finance Locks in Rajiv C. Lochan for Second Term as MD
- Bajaj Housing Finance Strengthens Board, Former RBI Executive Director Ajay Kumar Choudhary Joins as Independent Director
- Shree Rama Multi-Tech Appoints Shalin S. Patel as Additional Director
- Dr. Madhu Sharma Joins CGA as Senior Deputy Controller General of Accounts
